Cardinal Health Earnings Report: Key Highlights from Q1 2025 Results
Cardinal Health Q1 Earnings Overview
Cardinal Health (NYSE: CAH), a prominent name in healthcare and pharmaceuticals, reported its earnings for the first quarter of 2025. Despite a 4% revenue decline to $52.3 billion, the company achieved an impressive increase in adjusted profit. Net income surged to $416 million, equating to $1.70 per share, which marks a remarkable turnaround from the previous year's loss.
Key Financial Metrics
- Adjusted Earnings: Increased 9% YoY to $1.88 per share
- Operating Earnings: Rose 12% to $625 million
- Revenue Insight: Excluding a significant contract expiration, revenue saw a growth of 15%
Future Outlook and Stock Analysis
The firm has raised its full-year earnings guidance to a range between $7.75 and $7.90 per share, demonstrating confidence in ongoing profitability. Analysts are closely watching CAH stock price today as investor sentiment shifts. For detailed insights, including CAH stock forecast and market trends, stay informed about Cardinal Health's developments.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.